miRNAs and mRNAs in Psoriasis
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Psoriasis
Related studies linked through entity extraction aliases.
A Phase 3 Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)
- Status
- COMPLETED
- Phase
- PHASE3
A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, PD & PK of Calcipotriene 0.005% Foam, Under Maximal Use in 12-16 Year Olds With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
Vascular Inflammation in Psoriasis Trial (The VIP Trial)
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Ustekinumab to Evaluate a "Subject-tailored" Maintenance Dosing Approach in Subjects With Moderate-to-Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
- Status
- TERMINATED
- Phase
- PHASE4
Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg
- Status
- COMPLETED
- Phase
- PHASE1
Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis
- Status
- COMPLETED
- Phase
- NA
Influence of Atorvastatin on Psoriasis Severity and Endothelial Function
- Status
- WITHDRAWN
- Phase
- PHASE3
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
- Status
- TERMINATED
- Phase
- N/A
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
- Status
- COMPLETED
- Phase
- PHASE3
The Quality of Life Study in Psoriasis Patients After Ustekinumab Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 811 in Subjects With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
- Status
- UNKNOWN
- Phase
- N/A
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Effects of AMG 557 in Adults With Psoriasis
- Status
- TERMINATED
- Phase
- PHASE1
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2